76397-72-3

Basic information

• Product Name: 3-(CYANOACETYL)-2-METHYLINDOLE
• Synonyms: 3-(CYANOACETYL)-2-METHYLINDOLE;3-(2-METHYL-1H-INDOL-3-YL)-3-OXO-PROPIONITRILE;3-(2-methyl-1H-indol-3-yl)-3-oxopropanenitrile
• CAS NO: 76397-72-3
• Molecular Formula: C₁₂H₁₀N₂O
• Molecular Weight: 198.22
• Mol File: 76397-72-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 184 °C
• Boiling Point: 445.5 °C at 760 mmHg
• Flash Point: 223.2 °C
• Appearance: /
• Density: 1.242 g/cm³
• Vapor Pressure: 3.93E-08mmHg at 25°C
• Refractive Index: 1.646
• PKA: 8.63±0.30(Predicted)
• CAS DataBase Reference: 3-(CYANOACETYL)-2-METHYLINDOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(CYANOACETYL)-2-METHYLINDOLE(76397-72-3)
• EPA Substance Registry System: 3-(CYANOACETYL)-2-METHYLINDOLE(76397-72-3)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 76397-72-3(Hazardous Substances Data)

Usage

General Description

3-(Cyanoacetyl)-2-methylindole is a specific chemical compound. As suggested by its name, its structure combines a cyanacetyl group, a 2-methylindole group, and the connections between them. Indoles are aromatic heterocyclic organic compounds which have a bicyclic structure, consisting of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. In 2-methylindole, a methyl group is attached to the second carbon of the indole structure. Cyanoacetyl has a structure of H2C=C(CN)CO, where CN represents the cyano group. Detailed information about its properties such as molecular weight, boiling point, melting point, or potential uses in various applications are not widely provided or known, therefore further research and studies are required to reveal more information about this specific compound.

InChI:InChI=1/C12H10N2O/c1-8-12(11(15)6-7-13)9-4-2-3-5-10(9)14-8/h2-5,14H,6H2,1H3

Upstream product

• 95-20-5 2-methyl-1H-indole 
• 372-09-8 cyanoacetic acid 
• 7062-95-5 potassium 2-cyanoacetate 
• 38693-08-2 2-chloro-1-(2-methyl-1H-indol-3-yl)ethan-1-one 
• 151-50-8 potassium cyanide 

Downstream Products

• 1279650-23-5 2-[3,5-diphenyl-1,3,4-thiadiazol-2(3H)-ylidene]-3-(2-methyl-1H-indol-3-yl)-3-oxopropionitrile 
• 1279650-25-7 3-(2-methyl-1H-indol-3-yl)-2-[3-(4-nitrophenyl)-5-(thiophen-2-yl)-1,3,4-thiadiazol-2(3H)-ylidene]-3-oxopropionitrile 
• 1279650-26-8 ethyl 5-[1-cyano-2-(2-methyl-1H-indol-3-yl)-2-oxoethylidene]-4-phenyl-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate 
• 1279650-30-4 methyl 5-[1-cyano-2-(2-methyl-1H-indol-3-yl)-2-oxoethylidene]-4-phenyl-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate 
• 1279650-31-5 2-[5-acetyl-3-phenyl-1,3,4-thiadiazol-2(3H)-ylidene]-3-(2-methyl-1H-indol-3-yl)-3-oxopropionitrile 
• 1279650-32-6 3-(2-methyl-1H-indol-3-yl)-2-[3-phenyl-5-(thiophen-2-ylcarbonyl)-1,3,4-thiadiazol-2(3H)-ylidene]-3-oxopropionitrile 
• 1279650-34-8 2-[5-benzoyl-3-phenyl-1,3,4-thiadiazol-2(3H)-ylidene]-3-(2-methyl-1H-indol-3-yl)-3-oxopropionitrile 
• 1279650-38-2 5-(4-bromobenzoyl)-4-(2-methyl-1H-indol-3-yl)-2-(phenylamino)thiophene-3-carbonitrile 
• 1279650-39-3 5-acetyl-4-(2-methyl-1H-indol-3-yl)-2-(phenylamino)thiophene-3-carbonitrile 
• 1279650-40-6 ethyl 2-[1-cyano-2-(2-methyl-1H-indol-3-yl)-2-oxoethylidene]-4-methyl-3-phenyl-2,3-dihydrothiazole-5-carboxylate 
• 1279650-42-8 3-(2-methyl-1H-indol-3-yl)-2-[4-(2-oxochromen-3(2H)-yl)-3-phenylthiazole-2(3H)-ylidene]-3-oxopropionitrile 
• 1279650-43-9 3-(2-methyl-1H-indol-3-yl)-2-(3-phenylthiazolidin-2-ylidene)-3-oxopropionitrile 
• 1279650-47-3 2-(benzothiazol-2(3H)-ylidene)-3-(2-methyl-1H-indol-3-yl)-3-oxopropionitrile 
• 1279650-22-4 3-(2-methyl-1H-indol-3-yl)-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-3-oxopropionitrile 

Relevant articles and documents

Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations

Feline McDonough sarcoma (FMS)-like tyrosine kinase 3 (FLT3) is one of the most pursued targets in the treatment of acute myeloid leukaemia (AML) as its gene amplification and mutations, particularly internal tandem duplication (ITD), contribute to the pa

Synthesis and Biological Evaluation of Indolyl Bis-chalcones as Anti-Breast Cancer and Antioxidant Agents

A series of novel α-cyano substituted indolyl bis-chalcones (3a-l) has been synthesized and evaluated for their in vitro antitumor activity against the human breast cancer MCF7 (estrogen receptor-positive) and normal Vero cell lines using sulforhodamine B (SRB) assay method. Compounds 3a, 3c and 3d showed potent activity (GI50 = 11.7, 15.3 and 17.9 μM respectively) against the human breast cancer MCF7 cell line, which was almost as good as that of adriamycin (GI50 = 0.1 μM) whereas, screening against the normal Vero Monkey cell line showed moderate selectivity. Furthermore, all the synthesized compounds screened for their antioxidant potential against DPPH, NO, SOR, and H2O2 radicals. Most of the bis-chalcones exhibited significant DPPH (51.09-12.72 %) and NO (64.11-34.43 %) radical scavenging activity and modest activity against SOR (88.08-43.14 %) and H2O2 (80.13-56.0 %) radicals compared to the reference standard ascorbic acid (40.78 %, 42.63 %, 87.05 %, and 79.42 % respectively). Current study provides impetus for the development of highly potent indolyl bis-chalcone derivatives as anticancer leads.

Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents

In the present investigation, synthesis of a series of extended conjugated δ-chloro-α-cyano substituted indolyl chalcones (5a–p) was accomplished by reacting 3-cyanoacetylindole 2 with 3-chloro-3-phenyl-propenal 4 in the presence of piperidine. The struct